The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / U••••• V••• • V••••••• C••••••

A••••• C•••••• P••••••• Acquires U••••• V••• • V••••••• C••••••

Platform acquisitionclosedannounced Nov 29, 2022closed Nov 29, 2022Fact
What happened
Target
U••••• V••• • V••••••• C••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / healthcare
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • C••• Z••••••••Deal partnerconfirmed
    “C••• Z••••••••, Principal at A•••••, commented, “This investment represents a unique opportunity to partner with the leading management team in the vein and vascular space and deploy our extensive experience partnering with physician practice management companies to support UVVC’s next phase of grow”
  • J•• R•••Deal partnerconfirmed
    “J•• R•••, Managing Partner at A•••••, added, “An estimated 100 million Americans suffer from conditions that are treatable by UVVC, and they are increasingly seeking more convenient and comfortable outpatient care options.”
  • A••••• C•••••• P•••••••• L•••Sponsorconfirmed
    “A••••• C•••••• P•••••••, LP (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that it has acquired U••••• V••• • V••••••• C•••••• (“UVVC” or the “Company”), a leading provider of high-quality vascular care treatment services.”
Side not stated
  • U••••• V••• • V••••••• C••••••Targetconfirmed
    “A••••• C•••••• P•••••••, LP (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that it has acquired U••••• V••• • V••••••• C•••••• (“UVVC” or the “Company”), a leading provider of high-quality vascular care treatment services.”
Evidence
“A••••• C•••••• P•••••••, LP (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that it has acquired U••••• V••• • V••••••• C•••••• (“UVVC” or the “Company”), a leading provider of high-quality vascular care treatment services.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026
A••••• C•••••• P••••••• Acquires U••••• V••• • V••••••• C•••••• | Private Equity Intelligence | DFX